Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
surgical.ai Backs Caresyntax in $180M Series C Extension to Accelerate Adoption of AI-enabled Surgery
Life Sciences Times
-
August 15, 2024
0
Venture Capital
HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform
Life Sciences Times
-
August 15, 2024
0
Venture Capital
Jupiter Endovascular Exits Stealth With $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism
Life Sciences Times
-
August 15, 2024
0
Venture Capital
Kano Therapeutics Secures $7.1M to Bring Targeted, Non-Viral DNA Insertion Technology to Genetic Medicine
Life Sciences Times
-
August 12, 2024
0
Venture Capital
Bruker Announces Strategic Minority Investment in NovAliX
Life Sciences Times
-
August 7, 2024
0
Venture Capital
Spineology® Announces $25 Million Equity Financing
Life Sciences Times
-
August 6, 2024
0
Venture Capital
AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic
Life Sciences Times
-
July 31, 2024
0
Venture Capital
Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors
Life Sciences Times
-
July 25, 2024
0
Venture Capital
SoundHealth Receives $7 Million Seed-Round Funding and Launches SONU
Life Sciences Times
-
July 24, 2024
0
Venture Capital
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round
Life Sciences Times
-
July 24, 2024
0
Venture Capital
Agilent to Acquire North American CDMO BIOVECTRA
Life Sciences Times
-
July 22, 2024
0
Venture Capital
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
Life Sciences Times
-
July 10, 2024
0
1
...
26
27
28
...
115
Page 27 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026